Matthias Peipp
5PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 01, 2025
Memory-like Natural Killer Cell and CD19 Antibody-Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia.Zoya Eskandarian, Richard Hauch, Sabrina Schuster
|Jul 03, 2024
Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0.Chilam Chan, J H Marco Jansen, Ilona S T Hendriks
|Mar 22, 2024
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis.Lennart Lenk, Irène Baccelli, Anna Laqua
|Jun 19, 2023
Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.Lena Hänsch, Matthias Peipp, Maximilian Mastall
|Mar 24, 2022
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer.Matthias Peipp, Katja Klausz, Ammelie Svea Boje
Pageof 1
Frequent Collaborators
1 joint publications
Maximilian Mastall
1 joint publications
Dorothee Gramatzki
1 joint publications
Flavio Vasella
1 joint publications
Michael Weller
1 joint publications
Patrick Roth
1 joint publications
Lennart Lenk
1 joint publications
Beat Bornhauser
1 joint publications
Jean-Pierre Bourquin
1 joint publications
Simon Raffel
1 joint publications
Thomas Schüler
